≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Spinal enthesopathy

DOID EFO Endpoint Browser PheWeb

M13_SPINENTHES

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M46.0
  • Hospital discharge: ICD-8 — 7131
  • Cause of death: ICD-10 — M46.0
  • Cause of death: ICD-8 — 7131

2 out of 7 registries used, show all original rules.

1495

4. Check minimum number of events

None

1495

5. Include endpoints

None

1495

6. Filter based on genotype QC (FinnGen only)

1495

Control definitions (FinnGen only)

Control exclude
M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
M46
Name in latin
Enthesopathia spinalis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 33053 17098 15067
Only index persons 13197 8115 5082
Unadjusted period prevalence (%)
Whole population 0.47 0.49 0.42
Only index persons 0.26 0.30 0.19
Median age at first event (years)
Whole population 55.76 56.06 55.36
Only index persons 50.71 51.48 49.49

-FinnGen-

Key figures

All Female Male
Number of individuals 1495 596 899
Unadjusted period prevalence (%) 0.32 0.20 0.40
Median age at first event (years) 49.71 48.39 50.59

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1386
Matched controls
13853
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
71312
ICD-8 Finland
Osteo-arthritis and allied conditions, Spondylarthritis lumbalis sive lumbosacralis
+∞
323.0
594
*
71310
ICD-8 Finland
Osteo-arthritis and allied conditions, Spondylarthritis cervicalis
+∞
323.0
602
*
M46.0
ICD-10 Finland
Spinal enthesopathy
+∞
208.6
195
*
M48.0
ICD-10 Finland
Spinal stenosis
53.8
176.6
211
46
72870
ICD-8 Finland
Vertebrogenic pain syndrome, Lumbalgia
+∞
132.4
125
*
72510
ICD-8 Finland
Displacement of intervertebral disk, Lumbalis cum prolapsu disci
+∞
121.6
115
*
72880
ICD-8 Finland
Vertebrogenic pain syndrome, Radicula syndrome of lower limbs
+∞
105.5
100
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
35.3
96.9
126
39
71319
ICD-8 Finland
Osteo-arthritis and allied conditions, Spondylarthritis NUD
+∞
76.7
73
*
N02AX02
ATC
tramadol; systemic, rectal
2.9
69.9
619
3031
M45
ICD-10 Finland
Ankylosing spondylitis
230.4
64.7
66
*
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
70.1
58.7
67
10
M54.5
ICD-10 Finland
Low back pain
3.6
58.2
300
980
N03AX16
ATC
pregabalin; oral
3.6
57.9
296
960
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
20.5
57.7
87
45
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
+∞
56.6
54
*
71311
ICD-8 Finland
Osteo-arthritis and allied conditions, Spondylarthritis thoracica
+∞
54.5
52
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
7.6
53.1
130
186
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
95.3
50.2
55
6
71798
ICD-8 Finland
Other nonarticular rheumatism, Other muscular rheumatism, fibrositis and myalgia
30.9
48.7
65
22
N03AX12
ATC
gabapentin; oral
4.5
48.5
188
470
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
29.0
47.3
64
23
72820
ICD-8 Finland
Vertebrogenic pain syndrome, Diffuse syndrome cerviocobrachial
+∞
46.1
44
*
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
216.0
41.1
42
*
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
408.2
40.3
40
*
35399
ICD-8 Finland
Sciatica
12.6
39.7
72
60
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
6.1
39.3
112
197
M47.9
ICD-10 Finland
Spondylosis, unspecified
26.9
37.8
52
20
7210A
ICD-9 Finland
Spondylosis and allied disorders, Cervical spondylosis without myelopathy
+∞
37.6
36
*
72898
ICD-8 Finland
Vertebrogenic pain syndrome, Alia definita
+∞
37.6
36
*
7231A
ICD-9 Finland
Other disorders of cervical region, Cervicalgia
+∞
36.6
35
*
7240B
ICD-9 Finland
Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]
+∞
35.5
34
*
7213A
ICD-9 Finland
Spondylosis and allied disorders, Lumbosacral spondylosis without myelopathy
+∞
35.5
34
*
A07EC01
ATC
sulfasalazine; oral, rectal
4.2
34.5
139
357
M54.4
ICD-10 Finland
Lumbago with sciatica
4.8
33.7
117
259
72800
ICD-8 Finland
Vertebrogenic pain syndrome, Cervicalgia
36.0
32.9
42
12
9212
FHL
Other posterior root decompression surgery (eg laminectomy, Gill)
323.6
32.0
32
*
72899
ICD-8 Finland
Vertebrogenic pain syndrome, Other and unspecified
+∞
31.3
30
*
78050
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Vertigo
7.1
29.9
75
111
72830
ICD-8 Finland
Vertebrogenic pain syndrome, Radicular syndrome of upper limbs
+∞
28.2
27
*
N06AA09
ATC
amitriptyline; systemic
3.3
28.1
152
498
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
27.7
244
1088
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.0
27.5
175
642
M03BX02
ATC
tizanidine; oral
2.0
27.4
486
2969
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
13.9
26.9
46
34
9211
FHL
Exploration or removal of diskusprolapse
+∞
26.1
25
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
25.5
392
2254
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
14.3
25.4
43
31
71301
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) genus
7.0
25.3
63
93
M47.82
ICD-10 Finland
Other spondylosis, cervical region
15.6
25.1
41
27
N05BA01
ATC
diazepam; systemic, rectal
2.5
24.4
216
959
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
24.1
417
2495
N02AC04
ATC
dextropropoxyphene; oral
3.3
24.1
128
413
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
16.9
24.1
38
23
71300
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) coxae
9.5
23.8
49
53
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.9
22.9
76
161
71710
ICD-8 Finland
Other nonarticular rheumatism, Scapulohumeral myofibrosis
11.7
22.3
41
36
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
14.6
22.2
37
26
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.4
22.2
211
973
27799
ICD-8 Finland
Obesity not specified as of endocrine origin
10.5
22.1
43
42
40199
ICD-8 Finland
Essential benign hypertension
3.6
22.1
102
295
H02AB06
ATC
prednisolone; systemic
1.8
22.1
585
4032
71700
ICD-8 Finland
NA
+∞
21.9
21
*
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
63.5
21.9
25
*
M25.5
ICD-10 Finland
Pain in joint
2.3
21.6
221
1053
M54.3
ICD-10 Finland
Sciatica
6.8
21.6
55
84
M54.2
ICD-10 Finland
Cervicalgia
5.7
21.6
63
115
N06AX21
ATC
duloxetine; oral
3.9
20.9
88
235
7245A
ICD-9 Finland
Other and unspecified disorders of back, Backache, unspecified
+∞
20.9
20
*
A02BA02
ATC
ranitidine; systemic
2.0
20.8
341
1983
79199
ICD-8 Finland
Headache
8.4
20.5
45
55
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
21.1
20.0
29
14
M54.6
ICD-10 Finland
Pain in thoracic spine
6.1
19.8
54
91
M01AH02
ATC
rofecoxib; oral
2.4
19.7
188
865
L86
ICPC
Back syndrome with radiating pain
6.4
19.4
51
82
M43.1
ICD-10 Finland
Spondylolisthesis
18.5
19.1
29
16
A02BC05
ATC
esomeprazole; systemic
1.8
19.0
417
2668
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.8
19.0
467
3098
M03BC01
ATC
orphenadrine (citrate); systemic
2.6
18.8
152
637
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
192.2
18.6
19
*
M01AC06
ATC
meloxicam; systemic, rectal
1.8
18.1
364
2258
J01DA01
ATC
[U] cefalexin; systemic
1.6
18.0
787
6133
R07.3
ICD-10 Finland
Other chest pain
2.8
17.9
121
460
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
67.4
17.7
20
*
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
+∞
17.7
17
*
R03AC02
ATC
salbutamol; inhalant
1.7
17.3
523
3669
L03
ICPC
Low back symptom/complaint
2.3
17.2
176
834
30041
ICD-8 Finland
Neuroses, Depressiva
6.2
17.2
46
76
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.8
17.2
74
203
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.7
16.9
551
3940
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
9.6
16.9
34
36
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.1
16.9
97
332
M79.6
ICD-10 Finland
Pain in limb
1.9
16.8
310
1860
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
+∞
16.7
16
*
71308
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) alia (spinali excepta)
18.1
16.5
25
14
A02BC03
ATC
lansoprazole; oral
1.8
16.4
367
2347
R06.0
ICD-10 Finland
Dyspnoea
1.8
16.3
322
1977
M01AX17
ATC
nimesulide; oral
1.9
16.3
298
1780
40299
ICD-8 Finland
Hypertensive heart disease
4.9
16.3
53
111
M01AH01
ATC
celecoxib; oral (coxibs)
2.1
16.2
204
1060
R51.80
ICD-10 Finland
Headache
2.6
16.1
121
488
A02BC01
ATC
omeprazole; systemic
1.7
16.0
391
2566
M01AE03
ATC
ketoprofen; systemic, rectal
1.7
15.9
462
3183
71240
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica
+∞
15.6
15
*
M46.4
ICD-10 Finland
Discitis, unspecified
+∞
15.6
15
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.0
15.5
234
1303
M01AH05
ATC
etoricoxib; oral
1.7
15.3
427
2906
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
15.2
300
1839
75618
ICD-8 Finland
Other congenital anomalies of musculoskeletal system, Maleformationes columnae vertebralis aliae
20.3
15.1
22
11
M54.1
ICD-10 Finland
Radiculopathy
9.0
15.0
31
35
41399
ICD-8 Finland
Angina pectoris, Without mention of hypertensive disease
3.7
14.7
64
178
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
+∞
14.6
14
*
73599
ICD-8 Finland
Other and unspecified curvature of spine
+∞
14.6
14
*
M47.8
ICD-10 Finland
Other spondylosis
+∞
14.6
14
*
E9999
ICD-8 Finland
Late effect of injury due to war operations
11.0
14.5
27
25
G44.2
ICD-10 Finland
Tension-type headache
2.6
14.4
104
411
N05CF01
ATC
zopiclone; oral
1.6
13.9
483
3468
L04AB01
ATC
etanercept; parenteral
13.7
13.7
23
17
72850
ICD-8 Finland
Vertebrogenic pain syndrome, Pain in thoracic spine
+∞
13.6
13
*
C01DA14
ATC
isosorbide mononitrate; oral
1.6
13.5
408
2819
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
13.3
847
6991
Y0599
ICD-8 Finland
Investigation of digestive system
4.0
13.3
52
132
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
7.3
13.3
31
43
M13.9
ICD-10 Finland
Arthritis, unspecified
3.0
13.1
77
268
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
13.1
250
1508
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
12.8
463
3339
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.9
12.8
78
277
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.3
12.7
115
514
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
4.1
12.7
49
123
M79.0
ICD-10 Finland
Rheumatism, unspecified
6.9
12.7
31
46
M01AB05
ATC
diclofenac; systemic, rectal
1.5
12.7
610
4704
J01AA02
ATC
doxycycline; systemic
1.5
12.6
891
7482
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
70.4
12.6
14
*
XA402
NOMESCO Finland
ENMG
8.3
12.5
27
33
M46.3
ICD-10 Finland
Infection of intervertebral disc (pyogenic)
+∞
12.5
12
*
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
+∞
12.5
12
*
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
+∞
12.5
12
*
M48.9
ICD-10 Finland
Spondylopathy, unspecified
+∞
12.5
12
*
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.8
12.5
82
307
M01AB55
ATC
diclofenac, combinations; oral
2.4
12.5
110
483
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
12.3
195
1100
71303
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) multiplex
11.8
11.8
21
18
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.5
11.8
91
373
78739
ICD-8 Finland
Symptoms referable to limbs and joints, Arthralgia alia sive NUD
14.8
11.8
19
13
UJF32
NOMESCO Finland
Coloscopy
1.7
11.7
280
1804
41299
ICD-8 Finland
Chronic ischaemic heart disease, Without mention of hypertensive disease
5.1
11.7
36
72
A06AD11
ATC
lactulose; oral
1.6
11.6
311
2066
N06AB04
ATC
citalopram; systemic
1.7
11.6
262
1659
J01FA06
ATC
roxithromycin; oral
1.5
11.6
455
3329
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
+∞
11.5
11
*
72519
ICD-8 Finland
Displacement of intervertebral disk, Lumbalis et lumbosacralis NUD
+∞
11.5
11
*
R42
ICD-10 Finland
Dizziness and giddiness
1.7
11.2
285
1866
I20.09
ICD-10 Finland
Unstable angina
2.2
11.0
120
583
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.0
10.7
62
215
M70.6
ICD-10 Finland
Trochanteric bursitis
2.3
10.6
101
462
R06AE07
ATC
cetirizine; oral
1.6
10.6
366
2588
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
2.3
10.6
101
464
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
10.6
172
978
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
10.6
105
489
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
10.5
315
2152
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
+∞
10.4
10
*
7228C
ICD-9 Finland
Intervertebral disk disorders, Postlaminectomy syndrome[SYNDROMA LUMBOSACRALE POSTLAMINECTOMIAM]
+∞
10.4
10
*
72500
ICD-8 Finland
Displacement of intervertebral disk, Cervicalis cum prolapsu disci
+∞
10.4
10
*
7214A
ICD-9 Finland
Spondylosis and allied disorders, Thoracic or lumbar spondylosis with myelopathy
+∞
10.4
10
*
7225A
ICD-9 Finland
Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGENERATIO DISCI INTERVERTEBRALIS THORAC SEU LUMB]
+∞
10.4
10
*
72810
ICD-8 Finland
Vertebrogenic pain syndrome, Cervicocranial syndrome
+∞
10.4
10
*
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
10.3
205
1246
J46
ICD-10 Finland
Status asthmaticus
4.0
10.2
40
103
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
2.7
10.2
68
258
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
5.5
10.1
29
54
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
10.1
423
3121
72410
ICD-8 Finland
Internal derangement of joint, Other shoulder derangement
3.0
10.0
58
201
45599
ICD-8 Finland
Haemorrhoids
2.6
10.0
72
286
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.9
9.9
156
878
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.8
9.8
61
220
M54.8
ICD-10 Finland
Other dorsalgia
4.8
9.8
31
65
A03CA02
ATC
clidinium and psycholeptics; oral
2.2
9.7
98
463
42700
ICD-8 Finland
Symptomatic heart disease, Congestive heart failure
3.9
9.7
39
103
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
7.4
9.7
22
30
M19.9
ICD-10 Finland
Arthrosis, unspecified
3.3
9.7
47
145
N02AA05
ATC
oxycodone; systemic
1.7
9.7
203
1255
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
55.3
9.6
11
*
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
55.3
9.6
11
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
9.6
191
1157
A02BC02
ATC
pantoprazole; systemic
1.4
9.6
667
5434
M02AA10
ATC
ketoprofen; topical
1.8
9.5
177
1050
H02AB04
ATC
methylprednisolone; systemic
1.8
9.4
171
1012
72509
ICD-8 Finland
Displacement of intervertebral disk, Cervicalis NUD
+∞
9.4
9
*
7244A
ICD-9 Finland
Other and unspecified disorders of back, Thoracic or lumbosacral neuritis or radiculitis, unspecified
+∞
9.4
9
*
7233A
ICD-9 Finland
Other disorders of cervical region, Cervicobrachial syndrome (diffuse)
+∞
9.4
9
*
ABC30
NOMESCO Finland
Decompression of cervical nerve roots
+∞
9.4
9
*
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.1
9.4
104
511
A02BA04
ATC
nizatidine; systemic
1.9
9.3
144
805
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.9
9.3
142
792
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.4
9.2
78
336
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
9.2
87
399
A02BX02
ATC
sucralfate; oral
2.3
9.2
84
380
N05BA04
ATC
oxazepam; oral
1.5
9.0
300
2094
M50.3
ICD-10 Finland
Other cervical disc degeneration
18.7
8.9
13
7
41397
ICD-8 Finland
Angina pectoris, Suspecta, hypertonia non indicata
4.1
8.9
33
82
53503
ICD-8 Finland
Gastritis and duodenitis, Gastritis chronica NUD
8.7
8.8
18
21
78719
ICD-8 Finland
Symptoms referable to limbs and joints, Dolor extremitatis aliud sive NUD
9.5
8.8
17
18
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
8.7
130
718
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.6
8.7
259
1758
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
50.2
8.7
10
*
C03CA01
ATC
furosemide; systemic
1.4
8.7
617
5020
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
8.6
182
1125
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
8.6
456
3507
M01AE02
ATC
naproxen; oral, rectal
1.4
8.6
484
3768
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
8.5
195
1233
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
8.5
269
1849
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
27.6
8.5
11
*
B01AC07
ATC
dipyridamole; systemic
1.8
8.5
161
965
B01AB05
ATC
enoxaparin; parenteral
1.5
8.4
290
2037
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
8.4
328
2370
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
8.4
136
773
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
8.4
123
674
R05FB02
ATC
cough suppressants and expectorants
1.4
8.4
478
3726
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.7
8.3
163
982
7225B
ICD-9 Finland
Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGEN DISCI INTERVERT THORAC SEU LUMBOSACR CUM INST]
+∞
8.3
8
*
7249X
ICD-9 Finland
Other and unspecified disorders of back, Other unspecified back disorders
+∞
8.3
8
*
C07AA05
ATC
propranolol; systemic
1.8
8.3
158
946
M02AA07
ATC
piroxicam; topical
1.4
8.3
437
3350
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
2.2
8.2
83
394
R52.2
ICD-10 Finland
Other chronic pain
4.3
8.2
29
69
H04.10
ICD-10 Finland
Dry eye syndrome
2.2
8.2
77
353
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.4
8.1
66
282
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
8.1
501
3960
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.4
8.1
404
3068
X58
ICD-10 Finland
Exposure to other specified factors
2.0
8.0
101
525
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
3.2
8.0
40
128
M79.1
ICD-10 Finland
Myalgia
2.1
8.0
90
448
R03DC03
ATC
montelukast; oral
1.9
7.9
112
605
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.8
7.9
134
771
J02AC01
ATC
fluconazole; systemic
1.5
7.9
287
2033
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.5
7.9
58
234
N06AX16
ATC
venlafaxine; oral
2.2
7.9
75
346
L04AB04
ATC
adalimumab; parenteral
7.8
7.9
17
22
M01AX01
ATC
nabumetone; oral
2.7
7.8
51
193
N06AX03
ATC
mianserin; oral
2.5
7.8
58
236
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
8.5
7.8
16
19
41300
ICD-8 Finland
Angina pectoris, Cum hypertonia
4.0
7.8
29
73
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.9
7.8
24
50
N05CD07
ATC
temazepam; oral
1.5
7.7
254
1762
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
45.2
7.7
9
*
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
11.9
7.6
13
11
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
7.6
195
1274
N06AB03
ATC
fluoxetine; oral
1.9
7.5
103
551
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
7.5
285
2037
R03AC03
ATC
terbutaline; inhalant
1.8
7.5
136
804
K59.0
ICD-10 Finland
Constipation
2.0
7.5
91
467
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.8
7.5
46
169
M01AC01
ATC
piroxicam; systemic, rectal
1.7
7.5
149
905
M01AE51
ATC
ibuprofen, combinations; systemic
4.1
7.5
27
66
A03FA02
ATC
cisapride; oral, rectal
1.8
7.5
125
718
A03DA02
ATC
pitofenone and analgesics; systemic
2.9
7.5
44
157
L88
ICPC
Rheumatoid/seropositive arthritis
3.1
7.4
38
124
WX308
NOMESCO Finland
Sacral anesthesy
80.4
7.4
8
*
L04AB06
ATC
golimumab; parenteral
13.4
7.4
12
9
R53
ICD-10 Finland
Malaise and fatigue
1.5
7.3
264
1869
79019
ICD-8 Finland
Nervousness and debility, Debilitas et fatigatio abnormis alia sive NUD
+∞
7.3
7
*
72599
ICD-8 Finland
Displacement of intervertebral disk, Unspecified site
+∞
7.3
7
*
7242A
ICD-9 Finland
Other and unspecified disorders of back, Lumbago
+∞
7.3
7
*
7221A
ICD-9 Finland
Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy
+∞
7.3
7
*
72840
ICD-8 Finland
Vertebrogenic pain syndrome, Cervial myelopathy
+∞
7.3
7
*
M54
ICD-10 Finland
Dorsalgia
2.2
7.3
71
332
P01BA02
ATC
hydroxychloroquine; oral
2.2
7.3
73
344
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.0
7.3
27
68
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
5.5
7.2
20
37
M01AG02
ATC
tolfenamic acid; oral, rectal
1.9
7.2
102
555
72398
ICD-8 Finland
Other diseases of bone, Alii definiti
20.1
7.1
10
5
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.3
7.1
62
275
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.0
7.1
39
134
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.6
7.1
169
1082
N02BE01
ATC
paracetamol; systemic, rectal
1.4
7.1
886
7817
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
3.2
7.1
35
112
G04CA02
ATC
tamsulosin; oral
1.4
7.1
358
2712
35708
ICD-8 Finland
Other diseases of peripheral nerves except autonomic, Alterius nervi
8.8
7.0
14
16
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
7.0
418
3262
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
10.1
7.0
13
13
49099
ICD-8 Finland
Bronchitis, unspecified
4.3
7.0
24
56
J01DB01
ATC
cefalexin; oral
1.4
6.9
774
6688
M04AA01
ATC
allopurinol; systemic
1.5
6.9
217
1483
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.7
6.9
44
163
J01DA08
ATC
[U] cefaclor; oral
2.1
6.9
77
381
S22.3
ICD-10 Finland
Fracture of rib
2.1
6.7
74
365
4130X
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]
2.1
6.7
76
379
R52.9
ICD-10 Finland
Pain, unspecified
2.2
6.7
64
295
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.2
6.7
33
106
SPAT1229
SPAT
Assessment of need for aid
1.8
6.7
102
571
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
2.8
6.6
39
140
L17
ICPC
Foot/toe symptom/complaint
1.6
6.6
192
1289
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
4.6
6.6
21
46
N05CD05
ATC
triazolam; oral, sublingual
2.8
6.6
39
141
A02BA03
ATC
famotidine; systemic
2.0
6.5
77
390
C07AB02
ATC
metoprolol; systemic
1.4
6.5
373
2885
A07EC02
ATC
mesalazine; oral, rectal
2.3
6.5
55
241
C02DE04
ATC
NA
1.9
6.5
89
480
R01BA52
ATC
pseudoephedrine, combinations; oral
1.5
6.5
212
1467
34609
ICD-8 Finland
Migraine, Unspecified
6.2
6.5
16
26
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
6.4
264
1915
L85
ICPC
Acquired deformity of spine
70.0
6.4
7
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
6.4
177
1177
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
2.0
6.4
82
430
62699
ICD-8 Finland
Disorders of menstruation, Other
2.7
6.3
41
155
ZXA05
NOMESCO Finland
Left side
1.4
6.3
296
2203
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.8
6.3
110
644
7865A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Chest pain
2.9
6.3
36
125
E990A
ICD-9 Finland
Injury due to war operations by fires and conflagrations
5.5
6.3
17
31
AA1AD
NOMESCO Finland
CT of head and brain
1.5
6.3
274
2009
71599
ICD-8 Finland
Arthritis, unspecified
11.1
6.3
11
10
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
9.3
6.3
12
13
7227A
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[KAULANIKAMAN VÄLILEVYTYRÄ JUURIOIREINEEN]
+∞
6.2
6
*
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
+∞
6.2
6
*
M48.1
ICD-10 Finland
Ankylosing hyperostosis [Forestier]
+∞
6.2
6
*
ABC99
NOMESCO Finland
Other decompressive operation on spinal cord or nerve root
+∞
6.2
6
*
7232A
ICD-9 Finland
Other disorders of cervical region, Cervicocranial syndrome
+∞
6.2
6
*
7373A
ICD-9 Finland
Curvature of spine, Kyphoscoliosis and scoliosis
+∞
6.2
6
*
55130
ICD-8 Finland
Other hernia of abdominal cavity without mention of obstruction, Diaphragmatic
4.8
6.2
19
40
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
2.3
6.2
56
253
WZA90
NOMESCO Finland
Other doctors statement
1.6
6.2
142
899
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
3.0
6.2
33
112
C01CA24
ATC
epinephrine; parenteral
3.0
6.2
33
112
H02.3
ICD-10 Finland
Blepharochalasis
2.2
6.1
56
256
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
6.1
367
2859
73398
ICD-8 Finland
Other diseases of muscle, tendon and fascia, Alii definiti
4.7
6.1
19
41
M01AB51
ATC
indometacin, combinations; oral, rectal
3.0
6.1
32
108
42798
ICD-8 Finland
Symptomatic heart disease, Alia arrhytmia definita
3.6
6.1
25
70
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
2.4
6.1
47
198
M53.3
ICD-10 Finland
Sacrococcygeal disorders, not elsewhere classified
12.6
6.1
10
8
SPAT1301
SPAT
No procedures
1.4
6.0
309
2338
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
6.0
247
1790
N02BA71
ATC
acetylsalicylic acid, combinations with psycholeptics; systemic
2.8
6.0
35
125

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
56
163
3.52
16.38
1.4
1.6
iu/ml
0.6
0.4
0.11
18
44
(3037522) Nuclear Ab [Titer] in Serum
128
628
2.13
13.50
1.5
1.3
titre
664.8
468.2
0.47
29
136
(3011397) Hemoglobin [Presence] in Urine by Test strip
266
1703
1.68
12.21
5.0
4.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
261
1723
1.62
10.52
5.7
4.5
kg/l
1.0
1.0
0.08
36
304
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
134
736
1.90
10.31
1.3
1.2
u/ml
14.9
17.1
0.09
63
245
(3006315) Basophils [#/volume] in Blood
457
3443
1.47
9.98
7.8
4.5
e9/l
0.1
0.0
0.48
409
2892
(3001604) Monocytes [#/volume] in Blood
453
3418
1.46
9.78
7.7
4.5
e9/l
0.6
0.6
0.19
408
2857
(3013115) Eosinophils [#/volume] in Blood
468
3556
1.46
9.74
8.1
4.7
e9/l
0.2
0.2
0.66
427
3011
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
329
2335
1.52
9.59
2.3
2.2
u/l
49.0
57.5
6.14
306
2107
(3019198) Lymphocytes [#/volume] in Blood
462
3533
1.44
9.19
7.8
4.7
e9/l
2.3
1.8
0.52
418
3016
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
137
793
1.80
8.92
1.2
1.2
iu/ml
16.0
42.0
6.30
48
263
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
49
191
2.61
8.77
1.4
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
33
104
3.22
8.63
1.0
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
93
484
1.98
8.40
1.5
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
103
564
1.88
8.02
2.6
1.9
ug/g
182.4
161.8
0.18
93
424
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
235
1611
1.54
7.93
2.0
1.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
510
4071
1.38
7.63
10.3
7.3
e9/l
4.2
4.5
2.67
464
3448
(3010144) Erythrocytes [#/volume] in Synovial fluid
23
62
3.75
7.62
1.5
1.2
e6/l
56129.1
227584.3
0.63
17
41
(3026493) Urate [Moles/volume] in Serum or Plasma
263
1878
1.48
7.28
2.7
2.6
umol/l
7883.3
10025.7
0.22
223
1545
(3035350) Ketones [Presence] in Urine by Test strip
470
3730
1.38
7.21
5.1
4.0
estimate
0.0
0.0
0.00
77
674
(3029937) Albumin [Presence] in Urine by Test strip
285
2080
1.45
7.04
5.6
4.2
estimate
0.0
0.0
0.88
71
621
(3000475) Leukocytes [#/volume] in Synovial fluid
41
164
2.54
7.02
1.7
1.4
e6/l
17064.1
20537.6
0.17
35
111
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
168
1100
1.59
6.91
1.9
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
474
3793
1.36
6.83
5.1
4.1
estimate
0.0
0.0
0.50
76
665
(3022217) INR in Platelet poor plasma by Coagulation assay
220
1535
1.50
6.80
30.3
30.8
inr
1.5
1.6
0.31
25
193
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
97
551
1.81
6.76
1.6
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
35
135
2.63
6.46
1.7
1.9
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
76
410
1.90
6.24
2.8
2.5
g/l
11.4
10.7
0.53
65
364
(40760892) CBC W Ordered Manual Differential panel - Blood
192
1326
1.51
6.22
5.7
4.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
465
3758
1.34
6.16
6.5
5.5
estimate
0.0
0.0
0.50
78
663
(3007853) Bacteria identified in Skin by Aerobe culture
139
895
1.61
6.13
1.8
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
165
1106
1.55
6.13
1.9
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
244
1773
1.45
6.12
7.5
5.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
61
310
2.01
5.97
1.2
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
23
74
3.14
5.88
1.1
1.2
u/l
59.9
55.2
0.18
18
43
(3013707) Erythrocyte sedimentation rate by Westergren method
632
5362
1.31
5.86
5.8
3.6
mm/h
17.5
16.2
0.99
588
4760
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
387
3070
1.35
5.74
3.8
3.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
62
322
1.96
5.72
1.7
1.8
g/l
1.5
1.6
0.21
53
281
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
440
3571
1.33
5.56
5.1
4.1
ng/l
179.3
81.1
0.33
349
2771
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
165
1132
1.51
5.51
1.2
1.2
u/ml
0.9
1.5
0.93
40
276
(4034850)
49
239
2.08
5.38
10.9
11.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
491
4062
1.31
5.37
5.4
5.1
umol/l
11.1
13.4
4.72
470
3780
(3018418) pH of Serum or Plasma
316
2452
1.36
5.37
4.2
3.5
ph
7.4
7.4
0.19
48
460
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
317
2468
1.36
5.26
2.2
2.0
u/l
187.5
267.7
1.15
296
2279
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
462
3803
1.31
5.22
5.6
5.1
mmol/l
1.2
1.2
1.49
427
3336
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
198
1425
1.45
5.21
1.5
1.5
mg/l
1.6
1.6
0.01
157
1117
(3019069) Monocytes/100 leukocytes in Blood
409
3319
1.32
5.11
8.3
5.0
%
8.7
9.0
0.66
386
3014
(42870588) Differential panel, method unspecified - Blood
305
2381
1.35
4.95
7.1
4.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
405
3301
1.31
4.87
7.9
4.7
%
2.8
2.8
0.13
383
2984
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
313
2462
1.34
4.83
2.4
2.2
mg/l
3.2
3.3
0.13
275
2007
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
189
1368
1.43
4.82
2.9
2.8
e6/l
1.0
1.5
1.88
121
794
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
269
2069
1.36
4.80
3.4
2.8
u/l
30.5
36.2
2.28
249
1946
(3000850) Epithelial cells [#/volume] in Urine
246
1871
1.37
4.71
2.7
2.7
e6/l
5.3
5.5
0.05
213
1636
(3022096) Basophils/100 leukocytes in Blood
393
3204
1.30
4.69
7.8
4.7
%
0.6
0.6
0.05
371
2899
(40761535) Cells panel - Urine sediment
108
702
1.58
4.62
4.0
3.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
188
1377
1.42
4.49
2.4
2.3
umol/l
11.1
11.4
0.26
169
1232
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
20
70
2.88
4.48
1.6
1.4
%
59.1
70.9
0.63
15
47
(3000494) Fungus identified in Specimen by Culture
107
702
1.56
4.41
1.4
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
441
3675
1.28
4.41
4.8
4.1
g/l
34.4
34.0
0.92
403
3287
(3042936) Bacteria identified in Isolate by Culture
153
1085
1.45
4.36
2.1
1.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
22
4.56
4.29
2.6
2.1
u/ml
772.1
1594.7
—
10
22
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
9
8.91
4.27
1.1
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
18
62
2.92
4.16
1.6
1.2
%
44.0
22.1
1.27
12
40
(3017181) Myelocytes/100 leukocytes in Blood
89
569
1.60
4.11
4.8
3.6
%
1.8
0.9
0.89
31
179
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
226
1732
1.36
4.11
4.7
3.9
ng/l
408.0
285.9
0.26
190
1528
(3026008) Bacteria identified in Urine by Culture
372
3060
1.28
4.08
4.3
3.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
401
3331
1.28
4.07
7.8
4.8
%
57.8
60.2
3.18
380
3037
(3007164) IgA [Mass/volume] in Serum or Plasma
142
1009
1.45
4.01
1.5
1.4
g/l
2.6
2.6
0.13
88
551
(3013826) Glucose [Moles/volume] in Serum or Plasma
553
4780
1.25
3.97
4.8
4.1
mmol/l
7.0
7.0
0.18
533
4455
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
102
680
1.53
3.94
2.0
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
97
640
1.55
3.93
1.3
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
408
3409
1.27
3.93
8.1
5.0
%
26.3
24.5
2.13
385
3070
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
366
3018
1.28
3.92
2.6
2.1
nmol/l
79.6
77.8
0.55
326
2539
(3001122) Ferritin [Mass/volume] in Serum or Plasma
381
3158
1.27
3.91
3.0
2.7
ug/l
159.1
148.0
0.28
346
2751
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
32
151
2.14
3.90
1.2
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
335
2740
1.28
3.82
4.3
3.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
86
556
1.58
3.81
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
394
3290
1.27
3.79
2.6
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
406
3404
1.26
3.78
5.7
4.0
—
—
—
0
0
(3020891) Body temperature
59
350
1.71
3.67
3.2
3.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
360
2987
1.27
3.64
5.5
4.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
168
1253
1.38
3.63
2.4
2.3
g/l
2.2
2.3
1.16
156
1118
(3031040) Bacteria [#/volume] in Urine by Automated count
623
5506
1.22
3.52
6.7
5.0
e6/l
178.1
3110.7
1.96
14
117
(40768797) Stomach Pathology biopsy report
117
825
1.45
3.47
1.2
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
308
2527
1.27
3.40
2.8
2.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
116
820
1.45
3.40
3.5
2.2
umol/l
8.4
11.6
1.01
103
689
(3037467) Urinalysis macro (dipstick) panel - Urine
614
5432
1.22
3.40
6.0
4.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
94
641
1.49
3.31
1.6
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
7
8.58
3.26
1.2
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
26
122
2.15
3.25
1.2
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
33
170
1.96
3.24
1.5
1.4
ug/g
228.7
262.5
0.42
20
100
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
661
5911
1.21
3.23
8.7
6.3
u/l
83.7
83.5
0.02
631
5376
(3018095) Leukocytes [#/volume] in Urine
357
3000
1.25
3.20
4.5
3.7
e6/l
119.9
162.3
0.49
284
2196
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
65
412
1.60
3.18
5.7
6.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
25
118
2.13
3.09
1.6
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
368
3116
1.24
3.07
3.7
3.1
ng/l
1819.4
2674.8
3.44
334
2656
(4010399)
62
395
1.59
2.98
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
42
241
1.76
2.98
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
42
241
1.76
2.98
1.4
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
49
294
1.69
2.98
2.2
2.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
27
134
2.03
2.95
1.6
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
54
335
1.63
2.90
1.4
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
55
344
1.62
2.86
1.3
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
16
64
2.51
2.86
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
22
102
2.17
2.86
1.5
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
155
1189
1.34
2.83
2.4
2.4
%
20.3
20.7
0.15
128
983
(3024891) Influenza virus A+B Ag [Presence] in Specimen
36
201
1.81
2.81
1.3
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
23
110
2.10
2.78
3.5
6.3
mmol/l
7.6
7.7
0.06
16
96
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
486
4271
1.20
2.76
6.5
5.8
mmol/l
1.2
1.2
0.87
418
3464
(3003396) Base excess in Arterial blood by calculation
136
1029
1.35
2.73
4.4
5.0
mmol/l
1.1
1.4
0.45
106
779
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
24
3.76
2.67
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
24
3.76
2.67
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
265
2197
1.25
2.66
1.9
1.9
nmol/l
1235.5
1138.7
0.88
217
1574
(3021960) Folate [Moles/volume] in Serum or Plasma
260
2152
1.25
2.65
1.7
1.6
nmol/l
17.4
20.1
2.56
228
1775
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
88
622
1.44
2.64
1.8
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
24
121
2.00
2.55
1.2
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
11
5.46
2.54
1.0
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
313
2655
1.22
2.54
3.7
3.3
e6/l
89.9
123.2
0.32
266
2057
(3014111) Lactate [Moles/volume] in Serum or Plasma
101
738
1.39
2.52
4.3
4.8
mmol/l
1.6
1.4
0.34
96
696
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
168
1327
1.30
2.51
3.3
3.0
e6/l
2.6
2.5
0.03
101
758
(3017732) Neutrophils [#/volume] in Blood
63
421
1.52
2.51
3.1
3.0
e9/l
4.2
4.3
0.03
50
293
(3021440) Promyelocytes/100 leukocytes in Blood
77
537
1.45
2.49
5.1
3.7
%
0.4
0.1
0.88
23
167
(3002179) Metamyelocytes/100 leukocytes in Blood
73
504
1.47
2.48
4.6
3.6
%
1.0
0.7
0.38
20
127
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
98
715
1.39
2.48
2.3
1.8
g/l
0.2
0.2
0.29
89
642
(3020630) Protein [Mass/volume] in Serum or Plasma
98
719
1.39
2.40
2.9
2.2
g/l
66.9
65.1
1.49
88
617
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
8
6.25
2.37
1.2
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
76
535
1.44
2.35
2.6
3.7
mmol/l
2.0
2.2
0.20
56
383
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
21
104
2.03
2.35
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
116
880
1.34
2.32
2.9
2.3
ug/l
5.1
6.2
0.69
95
704
(3025159) Blasts/100 leukocytes in Blood
71
497
1.45
2.27
5.2
3.8
%
0.5
0.8
0.14
20
136
(3020961) Endomysium IgA Ab [Titer] in Serum
39
239
1.65
2.25
1.2
1.1
—
111.0
—
0
6
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
18
3.89
2.25
1.6
2.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
83
604
1.39
2.16
2.9
3.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
210
1738
1.24
2.15
3.0
3.0
mmol/l
2.5
2.5
0.36
175
1478
(3004588) Protein electrophoresis panel - Serum or Plasma
82
598
1.39
2.11
2.3
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
15
68
2.21
2.10
1.5
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
37
2.71
2.09
1.1
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
37
2.71
2.09
1.1
2.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
276
2356
1.21
2.09
3.7
3.2
e6/l
0.3
0.6
1.81
230
1820
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
16
75
2.14
2.08
1.3
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
77
559
1.40
2.05
2.6
3.7
ph
7.4
7.4
—
6
54
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
85
628
1.37
2.04
1.5
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
219
1834
1.22
2.02
2.7
2.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
75
544
1.40
2.01
2.0
1.8
nmol/l
376.0
405.2
0.59
65
478
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
73
527
1.40
2.01
2.7
3.0
ml/min/173m2
60.5
54.4
0.69
32
250
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
9
32
2.82
1.99
1.2
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
77
565
1.38
1.94
2.7
3.7
kpa
5.1
5.2
0.51
72
502
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
49
331
1.49
1.91
2.8
3.9
mmol/l
24.5
25.0
0.42
43
286
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
128
1015
1.28
1.90
10.9
8.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
155
1886
0.80
1.90
2.8
3.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
22
121
1.83
1.88
1.2
1.1
—
28.6
—
0
7
(3025577) Chromium [Mass/volume] in Blood
8
28
2.86
1.86
1.8
2.1
ug/l
1.1
1.8
—
8
19
(3045142) Bone marrow Pathology biopsy report
15
72
2.09
1.85
1.2
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
410
3659
1.16
1.84
2.3
2.1
pmol/l
95.9
91.8
0.88
219
1851
(3000991) Gas panel - Venous blood
91
693
1.33
1.82
5.1
5.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
262
2256
1.19
1.82
3.7
3.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
416
3721
1.16
1.81
12.4
11.6
inr
1.4
1.4
0.07
103
994
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
574
5257
1.15
1.80
4.2
3.6
pmol/l
15.0
15.2
0.92
519
4533
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
36
231
1.57
1.78
1.4
1.8
u/l
39.3
36.0
0.34
27
197
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
22
124
1.78
1.75
1.7
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
56
398
1.42
1.72
1.7
1.8
ug/l
0.4
2.7
2.02
47
328
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
36
236
1.54
1.65
1.5
1.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
69
2.04
1.64
1.0
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
87
670
1.31
1.64
3.0
2.1
u/l
29.5
33.4
0.73
69
549
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
454
4121
1.14
1.59
3.4
2.8
u/l
55.6
53.8
0.16
422
3677
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
59
430
1.38
1.59
2.1
1.8
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
218
1871
1.19
1.58
4.7
3.5
%
82.2
81.6
0.11
206
1813
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
73
950
0.76
1.56
4.5
4.3
%
35.6
33.4
0.78
55
588
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
306
1.45
1.54
2.8
2.0
g/l
3.3
3.3
0.07
35
221
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
184
1.58
1.54
1.1
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
78
1.93
1.53
1.1
1.2
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
7
27
2.60
1.51
1.4
1.3
%
28.2
14.9
—
7
22
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
185
1.58
1.51
1.1
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
21
2.86
1.50
2.8
2.0
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
120
978
1.24
1.47
3.1
3.4
u/l
241.1
251.1
0.36
113
895
(3022313) Gas panel - Capillary blood
56
411
1.37
1.47
2.5
3.7
—
—
—
0
0
(4062490)
9
38
2.37
1.45
1.2
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
28
2.50
1.45
1.0
1.3
nmol/l
125.0
127.9
—
7
28
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
102
1.77
1.44
1.4
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
188
1.55
1.42
1.1
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
23
361
0.63
1.40
4.5
4.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
40
2.25
1.40
1.1
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
38
264
1.45
1.36
2.9
1.8
g/l
36.3
36.4
0.02
33
201
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
17
2.94
1.35
1.0
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
15
82
1.83
1.35
1.1
1.1
—
26.8
—
0
11
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
15
82
1.83
1.35
1.5
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
120
1.67
1.33
4.5
3.0
%
59.1
60.9
0.18
20
120
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
24
2.50
1.30
1.0
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
10
48
2.09
1.27
1.2
1.7
e9/l
1.1
1.0
—
5
31
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
12
62
1.94
1.27
1.8
1.4
—
346.0
—
0
5
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
232
2041
1.16
1.27
1.9
1.7
pmol/l
433.1
6085745.5
0.79
206
1594
(3015377) Calcium [Moles/volume] in Serum or Plasma
319
2873
1.14
1.25
2.9
3.2
mmol/l
2.3
2.3
0.19
278
2378
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
31
211
1.48
1.25
1.5
1.7
—
—
—
0
0
(44813793)
6
25
2.40
1.24
1.2
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
336
3040
1.13
1.23
12.2
9.2
e9/l
0.0
0.0
0.50
283
2428
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
25
163
1.54
1.22
1.3
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
12
63
1.91
1.22
1.2
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
19
2.63
1.21
1.0
1.0
miu/ml
1910.8
1506.2
—
5
19
(3041354) Potassium [Moles/volume] in Venous blood
11
200
0.55
1.20
2.8
2.2
mmol/l
4.3
4.1
0.54
11
195
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
109
1.66
1.18
1.3
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
117
1.63
1.17
1.9
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
198
0.55
1.16
2.8
2.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
15
87
1.73
1.14
1.3
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
65
1.85
1.13
1.2
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
65
1.85
1.13
1.2
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
65
1.85
1.13
1.2
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
44
327
1.35
1.12
2.4
2.9
u/ml
9212.3
1701.3
0.38
39
274
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
53
406
1.31
1.11
3.4
3.0
mmol/l
23.1
24.0
0.77
43
358
(3044290) Cell count panel - Cerebral spinal fluid
15
88
1.71
1.11
1.1
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
31
2.26
1.10
1.3
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
96
1.67
1.09
1.3
1.1
—
1.2
—
0
6
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
18
112
1.61
1.08
1.2
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
339
1.34
1.06
2.8
1.9
g/l
4.1
3.7
0.68
35
215
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
33
2.12
1.05
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
33
2.12
1.05
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
33
2.12
1.05
1.4
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
22
2.27
1.03
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
23
154
1.50
1.03
2.5
2.6
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
34
2.06
1.02
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
34
2.06
1.02
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
34
2.06
1.02
1.4
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
95
790
1.21
1.02
2.9
2.6
kpa
4.4
4.4
0.12
90
746
(3003458) Phosphate [Moles/volume] in Serum or Plasma
130
1115
1.18
1.01
4.9
4.6
mmol/l
1.0
1.0
0.22
119
988
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
53
1.89
1.01
2.5
2.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
23
155
1.49
1.00
1.4
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
75
610
1.24
1.00
4.1
3.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
50
387
1.30
0.99
1.9
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
49
1.84
0.98
2.6
3.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
36
1.95
0.97
1.1
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
50
1.80
0.96
1.1
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
138
1581
0.86
0.96
3.1
3.1
ug/l
1.1
1.0
0.16
90
1118
(3051101) Glucose [Moles/volume] in Cord blood
0
32
0.00
0.95
0.0
6.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
125
1.52
0.93
1.3
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
27
2.22
0.93
1.0
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
63
508
1.25
0.92
3.5
3.6
%
50.6
46.8
0.61
63
498
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
70
1.72
0.92
1.1
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
10
55
1.82
0.91
1.9
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
23
159
1.45
0.90
1.3
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
15
94
1.60
0.90
1.5
1.6
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
6
29
2.07
0.89
1.7
1.6
nmol/l
1.0
0.9
—
6
18
(21494755) Public health laboratory ask at order entry panel
18
265
0.67
0.89
1.3
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
342
1.29
0.87
2.9
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
342
1.29
0.87
2.8
1.9
g/l
7.5
7.6
0.09
35
223
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
30
2.00
0.87
1.3
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
30
2.00
0.87
1.5
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
82
686
1.20
0.86
4.0
3.3
ng/l
118.7
99.0
0.44
69
539
(3017446) Testosterone [Moles/volume] in Serum or Plasma
49
387
1.27
0.86
1.4
2.1
nmol/l
11.4
10.9
0.17
42
340
(4268621)
8
44
1.82
0.85
2.6
2.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
68
559
1.22
0.85
1.2
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
108
928
1.17
0.85
3.2
3.0
mmol/l
2.0
2.1
0.07
78
690
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
239
1.34
0.83
1.2
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
44
345
1.28
0.82
1.2
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
108
931
1.17
0.82
3.2
3.0
kpa
5.9
5.8
0.10
103
885
(3047189) Immunofixation for 24 hour Urine
6
32
1.87
0.81
1.7
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
25
181
1.39
0.79
1.9
2.2
ug/min
151.2
83.6
0.42
15
105
(3009542) Hematocrit [Volume Fraction] of Blood
619
6463
0.92
0.78
25.1
18.1
%
37.9
37.1
1.07
361
3861
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
48
1.67
0.78
2.0
3.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
322
1.28
0.77
3.0
1.9
g/l
12.0
10.3
0.90
35
254
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
115
1.48
0.76
3.5
2.7
e9/l
4.8
4.9
0.02
17
115
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
55
449
1.23
0.75
4.9
6.5
mmol/l
23.9
24.6
1.11
50
399
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
278
0.71
0.75
1.6
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
83
1.57
0.74
2.0
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
184
0.65
0.74
1.5
1.4
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
7
38
1.84
0.73
1.3
1.6
umol/l
12.8
13.3
—
7
32
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
53
433
1.23
0.73
5.0
5.9
mmol/l
24.5
24.6
0.07
53
427
(3016018) Differential panel - Cerebral spinal fluid
7
39
1.80
0.72
1.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
28
211
1.33
0.71
1.1
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
117
1.46
0.71
1.2
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
26
1.92
0.70
1.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
26
1.92
0.70
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
57
472
1.21
0.70
1.7
1.7
%
1.5
1.5
0.22
49
404
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
37
292
1.27
0.69
1.2
1.2
iu/ml
98.5
155.6
0.67
16
108
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
27
1.85
0.68
1.4
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
33
257
1.29
0.68
3.8
3.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
10
61
1.64
0.68
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
69
1.60
0.68
1.2
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
18
127
1.42
0.67
3.9
2.5
umol/l
31.8
37.5
0.56
13
104
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
776
7489
1.07
0.67
24.9
16.4
mg/l
26.4
29.9
2.29
687
6135
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
28
1.79
0.66
1.0
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
48
394
1.22
0.65
1.2
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
44
1.59
0.65
1.1
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
29
1.72
0.63
1.2
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
29
1.72
0.63
1.2
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
105
926
1.14
0.63
3.3
3.1
ng/l
206.6
337.0
2.85
100
834
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
29
225
1.29
0.62
1.0
1.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
618
5930
1.07
0.62
31.3
21.7
g/l
330.0
330.1
0.11
607
5782
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
79
1.52
0.62
1.3
1.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
15
104
1.44
0.62
3.5
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
71
1.55
0.61
1.9
1.8
—
—
—
0
0
(3026782) Osmolality of Urine
202
1856
1.10
0.61
3.0
2.8
mosm/kgh2o
527.4
556.7
1.39
171
1572
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
52
1.54
0.59
1.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
72
1.53
0.58
1.2
1.3
—
—
—
0
0
(4281824)
10
64
1.56
0.58
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
23
175
1.32
0.57
2.5
3.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
669
6906
0.94
0.57
5.0
4.7
mmol/l
2.5
2.5
0.46
603
6045
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
81
1.48
0.56
1.8
1.8
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
27
211
1.28
0.56
1.6
1.7
—
172.0
—
0
10
(3000034) Microalbumin [Mass/volume] in Urine
11
73
1.51
0.56
1.9
3.3
mg/l
53.0
20.6
—
6
58
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
37
1.62
0.55
1.2
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
37
1.62
0.55
1.2
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
37
1.62
0.55
1.2
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
37
1.62
0.55
1.0
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
54
458
1.18
0.55
2.3
2.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
13
90
1.45
0.55
1.5
2.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
53
449
1.18
0.55
1.4
1.6
g/l
1.4
1.6
0.39
43
373
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
53
450
1.18
0.53
2.9
2.1
%
0.8
0.7
1.31
45
431
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
61
1.48
0.53
1.3
1.7
—
—
—
0
0
(3013512) EKG study
237
2528
0.92
0.52
4.6
4.2
—
—
—
0
0
(44790048)
10
66
1.52
0.52
1.5
1.5
—
—
—
0
0
(44790049)
10
66
1.52
0.52
1.5
1.5
—
—
—
0
0
(44806118)
10
66
1.52
0.52
1.5
1.5
—
—
—
0
0
(44790047)
10
66
1.52
0.52
1.5
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
40
1.50
0.51
1.7
1.3
—
—
—
0
0
(4094501)
18
135
1.33
0.50
1.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
95
848
1.13
0.50
2.0
2.1
e9/l
69.8
66.9
0.29
72
646
(3044889) 12 lead EKG panel
538
5171
1.06
0.50
4.6
4.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
677
6963
0.95
0.49
4.8
4.6
mmol/l
6.1
6.1
0.06
609
5999
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
67
1.49
0.49
1.0
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
108
0.65
0.48
3.7
1.9
%
57.9
60.7
—
7
108
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
103
927
1.12
0.48
4.0
3.7
—
—
—
0
0
(4146454)
11
76
1.45
0.47
2.2
2.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
48
1.46
0.46
1.6
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
49
1.43
0.46
1.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
49
1.43
0.46
1.0
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
255
1.22
0.45
1.4
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
636
6538
0.95
0.44
4.3
4.2
mmol/l
1.4
1.4
1.51
574
5704
(40768795) Lymph node Pathology biopsy report
10
69
1.45
0.44
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
45
521
0.86
0.43
1.7
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
129
1185
1.09
0.42
2.0
2.0
%
1.9
1.7
0.53
111
984
(3042631) Mycobacterium sp identified in Specimen
15
113
1.33
0.42
2.0
2.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
32
1.56
0.42
1.2
1.2
—
—
—
0
0
(4211845)
5
32
1.56
0.42
3.4
3.2
—
—
—
0
0
(4306422)
8
57
1.40
0.42
1.1
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
8
57
1.40
0.42
1.1
1.1
%
103.9
114.5
—
8
52
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
87
1.38
0.42
1.3
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
58
1.38
0.41
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
58
1.38
0.41
1.3
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
39
332
1.18
0.41
3.2
3.3
nmol/l
0.8
0.9
1.03
29
258
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
96
1.35
0.41
1.0
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.4
—
3.1
—
0
11
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
157
1682
0.92
0.41
1.5
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
59
1.36
0.41
1.1
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
88
1.36
0.39
1.3
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
88
1.36
0.39
1.3
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
648
6638
0.95
0.38
4.4
4.2
mmol/l
4.3
4.4
0.73
600
5850
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
33
279
1.18
0.38
1.8
2.6
u/ml
275.7
101.6
0.52
33
269
(40768793) Breast Pathology biopsy report
11
147
0.75
0.37
1.4
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
12
89
1.35
0.37
7.7
5.7
mg/l
11.3
12.2
0.36
12
77
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
72
1.39
0.36
1.4
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
41
1.46
0.36
1.5
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
618
6328
0.96
0.35
3.9
3.8
mmol/l
1.3
1.2
1.78
558
5463
(3000330) Specific gravity of Urine by Test strip
47
532
0.88
0.35
3.5
3.9
—
—
—
0
0
(4024509)
12
90
1.33
0.35
1.7
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
90
1.33
0.35
1.3
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
219
2074
1.06
0.35
4.4
3.7
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
43
1.39
0.35
2.5
2.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
126
1.27
0.35
2.0
2.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
44
1.36
0.34
1.2
2.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
102
942
1.09
0.32
3.0
3.7
ug/l
21.8
20.8
0.03
85
786
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
52
1.35
0.31
1.1
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
52
1.35
0.31
1.1
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
53
1.32
0.30
1.9
3.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
53
1.32
0.30
1.0
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
800
8125
0.96
0.30
34.4
23.9
g/l
128.3
129.9
1.99
784
7824
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
13
102
1.27
0.29
1.2
1.6
nmol/l
44.8
42.8
0.13
13
97
(3035941) MCH [Entitic mass]
800
8124
0.96
0.29
33.9
23.6
pg
30.4
30.3
0.30
786
7824
(3026361) Erythrocytes [#/volume] in Blood
800
8124
0.96
0.29
34.1
23.7
e12/l
4.3
4.3
2.35
769
7677
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
35
306
1.15
0.29
2.8
2.8
—
—
—
0
0
(3010421) pH of Blood
27
231
1.17
0.29
5.6
3.7
ph
7.4
7.4
0.11
19
195
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
15
184
0.81
0.29
1.5
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
800
8122
0.96
0.29
34.1
23.7
e9/l
238.4
238.3
0.01
775
7726
(3024731) MCV [Entitic volume]
800
8122
0.96
0.29
34.0
23.7
fl
92.0
91.7
0.90
786
7821
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
106
0.75
0.29
1.6
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
801
8127
0.97
0.27
34.1
23.7
e9/l
7.8
7.1
0.84
768
7678
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
67
1.19
0.26
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
282
2717
1.04
0.26
2.3
2.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
9
72
1.25
0.25
1.2
1.5
pmol/l
224.9
219.4
—
9
67
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
169
1.18
0.25
3.0
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
61
662
0.92
0.25
5.8
4.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
212
0.85
0.24
1.9
1.5
—
—
—
0
0
(4035726)
58
630
0.92
0.24
1.5
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
91
0.77
0.22
3.6
3.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
93
0.75
0.22
1.1
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
40
1.25
0.22
1.0
1.6
umol/l
5.4
10.6
—
5
27
(3002256) Pathology report gross observation
89
945
0.94
0.22
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
333
1.11
0.22
3.3
2.2
u/ml
0.3
0.4
0.31
20
193
(3022806) Fractional oxyhemoglobin in Capillary blood
14
116
1.21
0.21
2.5
1.8
%
85.4
88.4
0.53
14
116
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
89
1.24
0.20
1.3
1.3
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
14
0.00
0.20
0.0
1.6
—
8.1
—
0
6
(40762365) Oxygen content in Arterial blood by calculation
0
14
0.00
0.20
0.0
3.1
—
14.1
—
0
14
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
80
1.25
0.20
1.2
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
80
1.25
0.20
1.3
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
13
108
1.20
0.19
1.5
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
50
1.20
0.19
1.2
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
52
1.15
0.19
2.7
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
52
1.15
0.19
1.2
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
90
1.22
0.19
1.2
1.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
32
289
1.11
0.18
1.9
1.4
—
9.4
—
0
8
(3000764) Benzodiazepines [Presence] in Urine
10
81
1.23
0.18
1.8
2.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
20
175
1.14
0.18
2.8
2.7
%
15.3
15.7
—
8
81
(3039162) Centromere protein B Ab [Units/volume] in Serum
7
58
1.21
0.18
1.3
1.1
—
23.3
—
0
5
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
664
6535
1.03
0.18
5.2
4.4
mu/l
2.0
2.1
1.01
609
5666
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
59
1.19
0.18
1.3
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
142
0.84
0.18
1.3
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
660
6679
0.98
0.17
6.6
6.2
mmol/mol
42.1
41.4
0.84
609
5916
(3002385) Erythrocyte distribution width [Ratio]
586
5761
1.03
0.17
27.8
20.1
%
14.1
14.0
0.58
569
5543
(40768443) Skin Pathology biopsy report
33
300
1.10
0.17
1.3
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
18
157
1.15
0.17
1.3
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
63
1.11
0.17
1.3
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
110
1.18
0.17
1.2
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
82
1.22
0.17
1.8
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
82
1.22
0.17
1.8
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
82
1.22
0.17
1.8
2.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
156
1502
1.04
0.17
1.6
1.5
mmol/l
1.3
1.3
0.39
135
1219
(3035880) pH of Pleural fluid
8
68
1.18
0.16
1.3
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
69
1.16
0.16
1.3
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
14
120
1.17
0.16
1.6
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
82
1.10
0.15
3.9
3.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
763
7691
0.98
0.14
13.6
9.4
u/l
23.5
23.6
0.09
735
7213
(40768800) Prostate Pathology biopsy report
14
159
0.88
0.13
1.2
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
169
0.88
0.13
4.3
2.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
69
722
0.95
0.13
3.4
3.4
mmol/l
1.2
1.2
0.74
60
601
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
660
6655
0.98
0.12
20.7
16.0
ml/min/173m2
70.8
68.7
1.57
567
5476
(3037121) Protein [Mass/volume] in Urine
32
297
1.08
0.12
2.5
2.8
g/l
0.2
0.3
—
6
108
(3004119) Hemoglobin [Mass/volume] in Venous blood
62
590
1.05
0.12
3.4
2.8
g/l
118.6
124.4
1.30
55
576
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
95
1.16
0.11
3.4
2.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
105
1.14
0.11
2.1
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
86
1.16
0.10
3.2
2.6
—
—
—
0
0
(1002224) Polysomnography panel
16
144
1.11
0.10
1.0
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
45
1.11
0.09
1.4
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
45
1.11
0.09
1.4
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
45
1.11
0.09
1.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
761
7546
1.01
0.08
21.4
16.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
40
380
1.05
0.08
2.4
2.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
65
1.08
0.08
1.6
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
67
1.04
0.08
1.7
2.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
68
1.03
0.07
1.6
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
74
0.81
0.07
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
11
98
1.12
0.07
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
85
871
0.97
0.07
4.8
4.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
94
0.85
0.06
1.1
1.5
—
—
—
0
0
(3000492) Spirometry study
47
487
0.96
0.06
1.6
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
230
2266
1.02
0.06
2.9
3.0
mmol/l
6.9
6.9
0.04
192
1833
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
26
246
1.06
0.06
1.4
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
237
2391
0.99
0.05
3.7
3.8
mg/mmol
8.2
11.1
0.55
151
1537
(3019550) Sodium [Moles/volume] in Serum or Plasma
785
7866
0.99
0.04
26.5
19.8
mmol/l
139.2
139.5
1.39
760
7513
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
179
1.06
0.04
1.6
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
22
209
1.05
0.04
3.8
2.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
787
7878
0.99
0.03
26.8
20.0
mmol/l
4.0
4.0
0.49
761
7508
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
224
2221
1.01
0.02
4.5
4.5
%
21.5
22.5
0.41
109
1177
(3051387) C reactive protein [Mass/volume] in Capillary blood
26
268
0.97
0.02
4.4
3.7
mg/l
22.9
32.2
1.07
15
185
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
14
147
0.95
0.02
1.7
1.6
iu/l
2.9
4.7
—
7
36
(40768806) Pleura Pathology biopsy report
14
133
1.05
0.01
1.6
1.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
776
7734
1.00
0.01
26.7
19.3
umol/l
88.0
87.6
0.08
776
7729
(3012516) Albumin [Mass/volume] in Urine
221
2214
1.00
0.01
3.0
3.1
mg/l
872.6
236.2
0.72
147
1437
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
16
159
1.00
0.00
1.9
1.8
g/l
3.9
3.7
0.16
16
148
(3019832) Treponema pallidum Ab [Presence] in Serum
24
238
1.01
0.00
1.3
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
18
179
1.00
0.00
5.4
4.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
20
201
0.99
0.00
6.4
3.9
mmol/l
4.1
2.7
0.84
13
125
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
113
0.97
0.00
1.1
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
282
2810
1.00
0.00
5.0
5.1
ug/l
5.3
6.5
0.21
246
2407
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
105
0.95
0.00
1.1
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
53
0.94
0.00
1.0
2.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
1.4
1.5
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
48.8
—
0
6
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
1.8
—
0
8
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.4
—
56.5
—
0
9
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
6
62
0.97
0.00
1.3
1.5
mosm/kgh2o
267.3
276.0
—
6
43
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
96
0.94
0.00
1.9
3.2
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
7
0.00
0.00
0.0
1.7
—
2342.9
—
0
7
(3016879) Cocaine [Presence] in Urine
8
79
1.01
0.00
2.0
2.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
52
0.96
0.00
1.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
80
1.00
0.00
1.1
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
5
56
0.89
0.00
1.0
1.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
7
69
1.01
0.00
1.3
1.2
nmol/l
0.7
0.6
—
7
63
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
16.2
—
0
7

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SPINENTHES and mortality.

Females

Parameter HR [95% CI] p-value
M13_SPINENTHES 1.453 [1.13, 1.87] 0.004
Birth year 0.996 [0.99, 1.01] 0.406

During the follow-up period (1.1.1998 — 31.12.2019), 96 out of 699 females with M13_SPINENTHES died.

Males

Parameter HR [95% CI] p-value
M13_SPINENTHES 1.31 [1.04, 1.65] 0.022
Birth year 0.987 [0.98, 1.0] 0.008

During the follow-up period (1.1.1998 — 31.12.2019), 135 out of 629 males with M13_SPINENTHES died.

Mortality risk

Mortality risk for people of age

years, who have M13_SPINENTHES.

N-year risk Females Males
1 0.127% 0.208%
5 0.821% 1.478%
10 2.233% 3.758%
15 4.166% 7.268%
20 7.308% 12.053%

Relationships between endpoints

↥

Index endpoint: M13_SPINENTHES – Spinal enthesopathy

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data